Join
Live feed
·
INSIDERFilingvia Quantisnow
Eliem Therapeutics Inc logo

Director Ra Capital Management, L.P. was granted 5,259,872 shares and bought $49,952,817 worth of shares (13,008,546 units at $3.84) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ELYM· Eliem Therapeutics Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELYM (Eliem Therapeutics Inc) and more on Quantisnow.